mephenytoin has been researched along with Sclerosis, Systemic in 2 studies
Mephenytoin: An anticonvulsant effective in tonic-clonic epilepsy (EPILEPSY, TONIC-CLONIC). It may cause blood dyscrasias.
mephenytoin : An imidazolidine-2,4-dione (hydantoin) in which the imidazolidine nucleus carries a methyl group at N-3 and has ethyl and phenyl substituents at C-5. An anticonvulsant, it is no longer available in the USA or the UK but is still studied largely because of its interesting hydroxylation polymorphism.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zangemeister, WH | 1 |
| Weisner, B | 1 |
| May, DG | 1 |
| Black, CM | 1 |
| Olsen, NJ | 1 |
| Csuka, ME | 1 |
| Tanner, SB | 1 |
| Bellino, L | 1 |
| Porter, JA | 1 |
| Wilkinson, GR | 1 |
| Branch, RA | 1 |
2 other studies available for mephenytoin and Sclerosis, Systemic
| Article | Year |
|---|---|
[A progressive systemic sclerosis like disease due to anticonvulsive therapy? (author's transl)].
Topics: Adolescent; Adult; Anticonvulsants; Dermatomyositis; Female; Humans; Lupus Erythematosus, Systemic; | 1977 |
Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoin.
Topics: Acetylation; Adult; Biotransformation; Dapsone; Debrisoquin; Disease Susceptibility; Female; Humans; | 1990 |